source
- FDA rejects Capricor's Duchenne cell therapy again, citing major trial flawsCapricor Therapeutics' deramiocel cell therapy for Duchenne muscular dystrophy was denied by the FDA for a second time. The agency highlighted significant issues with the trial design and data, le…
- Opinion: How Kennedy and MAHA could help stop measlesKennedy and MAHA say they aren’t anti-vaccine. They can prove it by promoting the MMR vaccine, writes Brinda Adhikari.STAT · 58m ago↗ source